Alpine Global Management, LLC Provention Bio, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 21, 2023
BUY
$6.7 - $24.21 $168,505 - $608,881
25,150 New
25,150 $606,000
Q1 2023

May 15, 2023
BUY
$6.7 - $24.21 $168,505 - $608,881
25,150 New
25,150 $606,000
Q1 2022

May 13, 2022
SELL
$3.4 - $7.88 $54,651 - $126,663
-16,074 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$5.59 - $7.39 $89,853 - $118,786
16,074 New
16,074 $90,000
Q1 2020

Apr 09, 2020
SELL
$5.42 - $17.75 $78,779 - $257,996
-14,535 Closed
0 $0
Q4 2019

Jan 16, 2020
BUY
$5.84 - $14.9 $84,884 - $216,571
14,535 New
14,535 $217,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email